Timo Littmann

424 total citations
17 papers, 227 citations indexed

About

Timo Littmann is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, Timo Littmann has authored 17 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 3 papers in Immunology. Recurrent topics in Timo Littmann's work include Receptor Mechanisms and Signaling (15 papers), Neuropeptides and Animal Physiology (10 papers) and Chemical Synthesis and Analysis (3 papers). Timo Littmann is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Neuropeptides and Animal Physiology (10 papers) and Chemical Synthesis and Analysis (3 papers). Timo Littmann collaborates with scholars based in Germany, Japan and United States. Timo Littmann's co-authors include Günther Bernhardt, Armin Buschauer, Takeaki Ozawa, Gerhard Wolber, Lukas Grätz, Michael Decker, Miho Tanaka, Irving W. Wainer, Michael Reinartz and Max Keller and has published in prestigious journals such as Analytical Biochemistry, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Timo Littmann

16 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timo Littmann Germany 11 183 136 47 30 20 17 227
Tamara A. M. Mocking Netherlands 9 266 1.5× 153 1.1× 97 2.1× 44 1.5× 69 3.5× 17 361
Sebastian Schneider Germany 9 297 1.6× 133 1.0× 19 0.4× 12 0.4× 10 0.5× 16 366
Ming-Yue Lee United States 9 347 1.9× 136 1.0× 49 1.0× 7 0.2× 26 1.3× 12 417
David Wifling Germany 12 244 1.3× 119 0.9× 8 0.2× 72 2.4× 14 0.7× 16 275
Pierre Matricon Sweden 12 316 1.7× 98 0.7× 18 0.4× 8 0.3× 33 1.6× 14 394
R.E. Hubbard United Kingdom 9 199 1.1× 87 0.6× 32 0.7× 11 0.4× 22 1.1× 12 326
Changxiu Qu China 7 260 1.4× 122 0.9× 9 0.2× 50 1.7× 12 0.6× 9 327
Raminta Venskutonytė Denmark 13 236 1.3× 140 1.0× 25 0.5× 8 0.3× 41 2.0× 20 323
Nicholas W. Griggs United States 12 277 1.5× 158 1.2× 13 0.3× 11 0.4× 51 2.5× 17 378

Countries citing papers authored by Timo Littmann

Since Specialization
Citations

This map shows the geographic impact of Timo Littmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Littmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Littmann more than expected).

Fields of papers citing papers by Timo Littmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Littmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Littmann. The network helps show where Timo Littmann may publish in the future.

Co-authorship network of co-authors of Timo Littmann

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Littmann. A scholar is included among the top collaborators of Timo Littmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Littmann. Timo Littmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Grätz, Lukas, et al.. (2022). Insertion of Nanoluc into the Extracellular Loops as a Complementary Method To Establish BRET-Based Binding Assays for GPCRs. ACS Pharmacology & Translational Science. 5(11). 1142–1155. 10 indexed citations
2.
Littmann, Timo, Takeaki Ozawa, & Günther Bernhardt. (2021). Quantitative Determination and Imaging of Gαq Signaling in Live Cells via Split-Luciferase Complementation. Methods in molecular biology. 2274. 69–78. 1 indexed citations
3.
Littmann, Timo, et al.. (2021). Shining light on the histamine H2 receptor: Synthesis of carbamoylguanidine-type agonists as a pharmacological tool to study internalization. Bioorganic & Medicinal Chemistry Letters. 52. 128388–128388.
4.
Alencastre, Inês S., Timo Littmann, André F. Maia, et al.. (2020). Fluorescent H2 Receptor Squaramide-Type Antagonists: Synthesis, Characterization, and Applications. ACS Medicinal Chemistry Letters. 11(8). 1521–1528. 5 indexed citations
5.
Grätz, Lukas, et al.. (2020). UR-DEBa242: A Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H3 and H4 Receptors. Journal of Medicinal Chemistry. 63(10). 5297–5311. 22 indexed citations
6.
Keller, Max, Lisa Schindler, Timo Littmann, et al.. (2019). Fluorescence Labeling of Neurotensin(8–13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity. ACS Medicinal Chemistry Letters. 11(1). 16–22. 20 indexed citations
7.
Littmann, Timo, Armin Buschauer, & Günther Bernhardt. (2019). Split luciferase-based assay for simultaneous analyses of the ligand concentration- and time-dependent recruitment of β-arrestin2. Analytical Biochemistry. 573. 8–16. 11 indexed citations
8.
Bermúdez, Marcel, et al.. (2019). Novel BQCA‐ and TBPB‐Derived M1 Receptor Hybrid Ligands: Orthosteric Carbachol Differentially Regulates Partial Agonism. ChemMedChem. 14(14). 1349–1358. 9 indexed citations
9.
Littmann, Timo, et al.. (2019). [3H]UR-DEBa176: A 2,4-Diaminopyrimidine-Type Radioligand Enabling Binding Studies at the Human, Mouse, and Rat Histamine H4 Receptors. Journal of Medicinal Chemistry. 62(17). 8338–8356. 8 indexed citations
10.
Bermúdez, Marcel, Carlo Matera, Enrique Claro, et al.. (2019). Fluorination of Photoswitchable Muscarinic Agonists Tunes Receptor Pharmacology and Photochromic Properties. Journal of Medicinal Chemistry. 62(6). 3009–3020. 39 indexed citations
11.
Littmann, Timo, Takeaki Ozawa, Carsten Hoffmann, Armin Buschauer, & Günther Bernhardt. (2018). A split luciferase-based probe for quantitative proximal determination of Gαq signalling in live cells. Scientific Reports. 8(1). 17179–17179. 17 indexed citations
12.
Littmann, Timo, et al.. (2018). Establishing a Split Luciferase Assay for Proteinkinase G (PKG) Interaction Studies. International Journal of Molecular Sciences. 19(4). 1180–1180. 3 indexed citations
14.
Littmann, Timo, et al.. (2017). Fluorescence- and Radiolabeling of [Lys4,Nle17,30]hPP Yields Molecular Tools for the NPY Y4Receptor. Bioconjugate Chemistry. 28(4). 1291–1304. 12 indexed citations
15.
Lieb, Spencer, Timo Littmann, Miho Tanaka, et al.. (2016). Label-free versus conventional cellular assays: Functional investigations on the human histamine H1 receptor. Pharmacological Research. 114. 13–26. 21 indexed citations
16.
Littmann, Timo, et al.. (2015). Recruitment of β-Arrestin 1 and 2 to the β2-Adrenoceptor: Analysis of 65 Ligands. Journal of Pharmacology and Experimental Therapeutics. 355(2). 183–190. 25 indexed citations
17.
Reinartz, Michael, Timo Littmann, Takeaki Ozawa, et al.. (2014). Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor. Naunyn-Schmiedeberg s Archives of Pharmacology. 388(1). 51–65. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026